Formulation, evaluation and comparison of sustained release matrix tablets of diclofenac sodium using tamarind gum as release modifier

Asian Journal of Pharmaceutical and Clinical Research

Volumn 3, Issue 3, 2010, Pages 238-241

  Malviya, Rishabha ^a   Srivastava, Pranati ^a   Bansal, Mayank ^a   Kumar Sharma, Pramod ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Diclofenac sodium; Gum acacia; Sustained release matrix tablet; Tamarind gum

Indexed keywords

DICLOFENAC; MICROCRYSTALLINE CELLULOSE; PLANT GUM; POLYMER; TAMARIND GUM; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISPERSIBLE TABLET; DRUG EFFICACY; DRUG FORMULATION; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROMETRY; PLANT SEED; SUSTAINED RELEASE PREPARATION; SWELLING; TABLET FRIABILITY; TABLET HARDNESS; TABLET MATRIX; TABLET THICKNESS; TAMARIND; TIMED DRUG RELEASE;

EID: 77957690504     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ansel HC, Loyyd VA. Pharmaceutical dosage forms and Drug Delivery System. Lippincott's Williams and Wilking, Hong Kong. 1999; 8: 275-280.
2. Gwen MJ, Joseph RR, Rhodes CT. Modern Pharmaceutics, Marcel Dekker, Inc., New York. 1996; 72(3): 58.
3. Langer RS, Peppas NA. Present and future application of biomaterials in controlled drug delivery systems. Biomaterials, 1981; 2(10): 201-213.
4. Rao PS, Srivastav HC, Tamarind. In Indusrtial Gums, (Ed.) R.L. Whistler, Academic Press, 2nd Ed, New York, 1973; 369-411.
5. Nandi RC. A Process for preparation of polyose from the seeds of Tamarindus indica. Ind. Pat, 1975; 142092.
6. Rao PS. Extraction and purification of tamarind seed polysaccharide. J Sci Ind Research, 1946; 4: 705.
7. Kulkarni D, Ddwivedi DK, Sarin JPS, Singh S. Tamarind seed polyose: A potential polysaccharide for sustained release of verapamil hydrochloride as a model drug. Indian J Pharm Sci, 1997; 59(1): 1-7.
8. Indian Pharmacopoeia. Ministry of health. The controller of publications, New Delhi. 1996; 4ed; 432.
9. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Release characteristics of diclofenac sodium from encapsulated natural gum mini-matrix formulations. Int J Pharm, 1996; 139: 53-62.
10. Sano, M, Miyata, E, Tamano, S, Hagiwara, A, Ito, N. and Shirai, T., Lack of carcinogenicity of tamarind seed polysaccharide in B6C3F mice, Food and Chem Toxicol, 34: 463-467, 1996.
11. Burgalassi, S., Panichi, L., Saettone, MF., Jacobsen, J. and Rassing, MR., Development and in vitro/ in vivo testing of mucoadhesive buccal patches releasing benzydamine and lidocaine. Int J Pharm, 133:1-7, 1996.
12. Kulkarni, D, Ddwivedi, DK., Sarin, JPS. and Singh, S., Tamarind seed polyose: A potential polysaccharide for sustained release of verapamil hydrochloride as a model drug. Indian J Pharm Sci, 59(1):1-7, 1997.
13. Kulkarni GT, Gowthamarajan K, Rao BG, Suresh B. Evaluation of binding properties of selected natural mucilages. Journal of Scientific and Industrial Research (India), 2002; 61: 529-532.
14. Kulkarni GT, Gowthamarajan K, Rao BG, Suresh B. Evaluation of binding properties of Plantago ovata and Trigonella foenum graecum mucilages. Indian Drugs, 2002; 39: 422-425.
15. Baveja SK, Rangarao KV, Arora J. Examination of natural gums and mucilages as sustaining materials in tablet dosage forms. Indian Journal of Pharmaceutical Sciences, 1988; 50: 89-92
16. Nokano M, Ogata A. In vitro release characteristics of matrix tablets: Study of Karaya gum and Guar gum as release modulators. Ind J Pharm Sc, 2006; 68(6): 824-826.
17. Gwen MJ, Joseph RR, Rhodes CT. Modern Pharmaceutics, Marcel Dekker, Inc, New York. 1996; 72(3): 581.
18. USP30-NF25, The official compendium of standards. The United States Pharmacopoeial Convention, 2007.
19. Lantz RJ, Schwartz JB. Tablets. In: Lieberman HA, Lachman L, editors. Pharmaceutical dosage forms. 2nd Ed. New York, USA: Marcel Dekker, Inc, 2005; 15-20, 69.
20. Khullar P, Khar RK, Agarwal SP. Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev Ind Pharm, 1998; 24: 1095-1109.
21. Krishnaiah YSR, Rama Rao T, Ushasree M, Satyanarayana S. A study on the in vitro evaluation of guar gum as a carrier for oral controlled drug delivery. Saudi Pharm J, 2001; 9: 91-98.
22. Sujja-areevath J, Munday DL, Cox PJ and Khan KA. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci, 1998; 6: 207-217.
23. Abrahamsson B, Alpsten M, Bake B, Larsson A, Sjogren J. In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. Eur J Pharm Biopharm, 1998; 46: 69-75.
24. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Release characteristics of diclofenac sodium from encapsulated natural gum mini-matrix formulation. Int J Pharm, 1996; 139: 53-62.
25. Ei-Arini SK, Leuenberger H. Modelling of drug release from polymer matrices: Effect of drug loading. Int J Phar, 1995; 121: 141-148.
26. Harland RS, Gazzaniga A, Sanagalli ME, Colombo P, Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm. Res., 1998; 5(8): 488-494.
27. Ritger PL, Peppas NA. A simple equation for description of solute release II Fickian and anomalous from swellable devices. J Control Rel, 1987; 5: 37-42.
28. Munday D L, Cox P J. Compressed xanthan and karya gum matrices: hydration, erosion and drug release mechanisms. Int J Pharm, 2000; 203: 179-182.